Skip to main content
. 2021 Nov 2;12:734671. doi: 10.3389/fphar.2021.734671

TABLE 7.

Chi-square analysis of arrhythmia inhibition rate between different experimental compounds and lidocaine.

Compound Dose (mg/kg) Arrhythmia (frequency) Without arrhythmia (frequency) χ 2 p
Compound 1 0.05–0.20 21 1 15.457 0.001
0.40 10 3
0.60 11 14
Lidocaine 5.0 12 9
Compound 2 0.05–0.20 22 2 18.123 0.0004
0.30 10 12
0.40 10 18
Lidocaine 5.0 12 9
Compound 4 0.05–0.20 21 2 6.908 0.032
0.40 19 6
Lidocaine 5.0 12 9